On the risk of further excluding outcast patient populations in South America

• Eloy Ruiz,
• Ramiro Fernández,
• Francisco Berrospi,
• Sandro Casavilca-Zambrano,
• Juan Contreras-Mancilla,
• Juan Pablo Cerapio,
• Pascal Pineau,
• Stéphane Bertani

Affiliations

Eloy Ruiz

Departamento de Cirugía en Abdomen, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Peru; International Joint Laboratory of Molecular Anthropological Oncology (LOAM), INEN, IRD, Lima, Peru

Ramiro Fernández

Departamento de Cirugía en Abdomen, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Peru; International Joint Laboratory of Molecular Anthropological Oncology (LOAM), INEN, IRD, Lima, Peru

Francisco Berrospi

Departamento de Cirugía en Abdomen, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Peru

Sandro Casavilca-Zambrano

International Joint Laboratory of Molecular Anthropological Oncology (LOAM), INEN, IRD, Lima, Peru; Departamento de Patología, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Peru; Biobanco de Tejidos Tumorales, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Peru

Juan Contreras-Mancilla

International Joint Laboratory of Molecular Anthropological Oncology (LOAM), INEN, IRD, Lima, Peru; Biobanco de Tejidos Tumorales, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Peru

Juan Pablo Cerapio

International Joint Laboratory of Molecular Anthropological Oncology (LOAM), INEN, IRD, Lima, Peru; UMR 1037 CRCT, Université de Toulouse, INSERM, UPS, Toulouse, France

Pascal Pineau

International Joint Laboratory of Molecular Anthropological Oncology (LOAM), INEN, IRD, Lima, Peru; Unité Organisation Nucléaire et Oncogenèse, INSERM, Institut Pasteur, Paris, France

Stéphane Bertani

International Joint Laboratory of Molecular Anthropological Oncology (LOAM), INEN, IRD, Lima, Peru; UMR 152 PHARMADEV, Université de Toulouse, IRD, UPS, Toulouse, France; Corresponding author.